MUNDELEIN, Ill., July 20 /PRNewswire/ — Sysmex, a global
leader in medical diagnostic testing equipment and information
systems technology, today announced the addition of the
CellaVision® DM1200 cell image analysis analyzer to the Sysmex
hematology product offering. The DM1200 enables Sysmex
America to meet the growing demand for automated cell image
analysis, which improves both the quality of results and the
productivity of laboratories performing mid-volume testing.
The CellaVision® DM1200 opens up new ways of handling manual
differentials traditionally performed on a microscope by
automatically performing a preliminary differential count on
peripheral blood. The analyzer pre-classifies the white blood
cells, pre-characterizes parts of the red morphology and provides
functionality for platelet estimation. By automating the manual
differential, laboratories can experience enhanced turnaround times
without sacrificing quality. Its high degree of automation
allows for an escalating workload without increasing labor.
“The CellaVision DM1200, which locates, identifies, and
pre-classifies blood cells by means of automatic microscopy and
advanced image processing, greatly enhances Sysmex America’s
hematology product offering. We trust this addition to our
hematology portfolio will serve our customers well as they continue
to navigate through a challenging health care environment,” said
John Kershaw, President & CEO,
Sysmex America, Inc.
Sysmex America and CellaVision first initiated their working
relationship in 2004. Today, Sysmex Corporation and
CellaVision have an extended and broadened working relationship via
the completion of a recent global distribution agreement. The
agreement gives S
‘/>”/>
